Erratum Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis: Erratum

I

n the article ‘‘Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis’’,1 which appeared in Volume 93, Issue 28 of Medicine, one of the authors’ affiliations, National Yang-Ming University School of Medicine, Taipei, Taiwan, was omitted. The article has since been corrected online.

REFERENCE 1.

Liu PH, Hsu CY, Lee YH, et al. Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: A propensity score analysis. Medicine 93(28):e264.

Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ISSN: 0025-7974 DOI: 10.1097/01.md.0000464208.55673.5b

Medicine



Volume 94, Number 4, January 2015

www.md-journal.com |

1

Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis: erratum.

[In the article "Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis", which appeared in V...
47KB Sizes 2 Downloads 8 Views
Download PDF

Recommend Documents

Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis.
Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis.
Survival outcomes of hepatocellular carcinoma resection with postoperative complications - a propensity-score-matched analysis.
Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.
Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis.
Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study.
Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score Analysis.
Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: a propensity score analysis.

Follow Us

Copyright © 2024 D.DOCKSCI.COM. All rights reserved. | Design by w3layouts